Karuna Therapeutics to Present at Upcoming Investor Conferences
01 November 2023 - 9:30PM
Business Wire
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical
company driven to discover, develop, and deliver transformative
medicines for people living with psychiatric and neurological
conditions, today announced that management will present at the
following upcoming investor conferences:
Guggenheim 5th Annual Inflammation & Immunology
Conference Date: Tuesday, November 7, 2023 Time: 1:50 p.m.
ET
Stifel 2023 Healthcare Conference Date: Tuesday, November
14, 2023 Time: 8:35 a.m. ET
A live webcast of the presentations will be available on the
Investor Relations page of Karuna’s website at
investors.karunatx.com. A replay of the webcasts will also be
archived for up to 30 days on Karuna’s website following the
completion of each event.
About Karuna
Karuna Therapeutics is a biopharmaceutical company driven to
discover, develop, and deliver transformative medicines for people
living with psychiatric and neurological conditions. At Karuna, we
understand there is a need for differentiated and more effective
treatments that can help patients navigate the challenges presented
by serious mental illness. Utilizing our extensive knowledge of
neuroscience, we are harnessing the untapped potential of the brain
in pursuit of novel pathways to develop medicines that make
meaningful differences in peoples’ lives. For more information,
please visit www.karunatx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231101355660/en/
Investors: Alexis Smith +1 (617) 352-9917
asmith@karunatx.com
Media: Julie Ciardiello +1 (917) 647-0159
julie.ciardiello@karunatx.com
Karuna Therapeutics (NASDAQ:KRTX)
Historical Stock Chart
From Apr 2024 to May 2024
Karuna Therapeutics (NASDAQ:KRTX)
Historical Stock Chart
From May 2023 to May 2024